Serum levels of IL-6 and its soluble receptor (sIL-6R) in Waldenström's macroglobulinemia

European Journal of Haematology

Volumn 66, Issue 1, 2001, Pages 1-6

  Hatzimichael, Eleftheria Ch R ^a   Christou, Leonidas ^a   Bai, Maria ^a   Kolios, George ^a   Kefala, Lambrini ^a   Bourantas, Konstantinos L ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Department of Haematology ^*  (Greece)

Author keywords

IL 6; sIL 6R; Waldenstr m's macroglobulinemia

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; BLOOD VISCOSITY; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN M; INTERLEUKIN-6; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-6; SOLUBILITY; WALDENSTROM MACROGLOBULINEMIA;

EID: 0035142437     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2001.00152.x     Document Type: Article

References (27)

1. Incidence of Waldenström's macrobulinemia
2. Waldenström's macrobulinemia
3. Bone marrow histology in Waldenström's macroglobulinemia. Clinical relevance of subtype recognition
4. Treatment of Waldenström's macroglobulinemia by plasmapheresis
5. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance
6. Fludarabine therapy in Waldenström's macrobulinemia
7. Treatment of Waldenström macrobulinemia with 2-chlorode-oxyadenosine
8. Interleukin 6 and its receptor: Ten years later
9. Purification and characterization of soluble IL-6 receptor expressed in CHO cells
10. Interleukin 6 in human multiple myeloma
11. Radioimmunoassay for the measurement of IL-6 and its correlation with tumor cell parameters in multiple myeloma
12. Interleukin 6 dependence of spontaneous in vitro differentiation of B cells from patients with IgM gammopathy
13. Soluble interleukin 6 receptor in biological fluids from human origin
14. Human soluble IL-6R: Its detection and enhanced release by HIV infection
15. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Grave's disease
16. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy
17. A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis
18. The biology of interleukin-6
19. Soluble cytokine receptors
20. Prognostic factors in Waldenström's macroglobulinemia: A report of 167 cases
21. Interleukin-6 is a prognostic factor in multiple myeloma
22. Serum levels of interleukin-6, a potent myeloma cell growth factor, a reflection of disease severity in plasma cell dyscrasias
23. The use of a commercially available immunoassay to determine the level of interleukin-6 in the serum of patients with myeloma
24. Diagnostic value of serum IL-6 level in monoclonal gammopathies
25. Serum levels of soluble receptor in multiple myeloma as indicator of disease activity
26. Soluble interleukin-6 receptor (sIL-6R), a new prognostic factor in multiple myeloma
27. The prognostic value of soluble interleukin-6 receptor in patients with multiple myeloma